SEC 13F Intelligence

Versant Venture Management, LLC / RPTX

Versant Venture Management, LLC’s Repare Therapeutics Inc Position

Does Versant Venture Management, LLC own Repare Therapeutics Inc (RPTX)? Not currently — the last reported position was 2.65M shares worth $5M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2025
Shares
2.65M
% of Portfolio
+2.19%
Quarters Held
10
position exited

Position History RPTX

Reported value by quarter
Q2 ’23: $28MQ2 ’23Q3 ’23: $32MQ4 ’23: $19MQ4 ’23Q1 ’24: $12MQ2 ’24: $9MQ2 ’24Q3 ’24: $9MQ4 ’24: $3MQ4 ’24Q1 ’25: $3MQ2 ’25: $4MQ2 ’25Q3 ’25: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20252.65M$5M+2.19%
Q2 20252.65M$4M+4.48%
Q1 20252.65M$3M+4.33%
Q4 20242.65M$3M+4.00%
Q3 20242.65M$9M+14.32%
Q2 20242.65M$9M+11.30%
Q1 20242.65M$12M+12.09%
Q4 20232.65M$19M+4.97%
Q3 20232.65M$32M+17.00%
Q2 20232.65M$28M+33.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of RPTX.